Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–10 influenza season: a multicentre, randomised controlled trial

This publication has 13 references indexed in Scilit:

• Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
  New England Journal of Medicine, 2009
• Influenza A (H5N1) pandemic prototype vaccine Fluval®
  Expert Review of Vaccines, 2009
• Cross-Reactive Immunity to Clade 2 Strains of Influenza Virus A Subtype H5N1 Induced in Adults and Elderly Patients by Fluval, a Prototype Pandemic Influenza Virus Vaccine Derived by Reverse Genetics, Formulated with a Phosphate Adjuvant, and Directed to Clade 1 Strains
  Clinical and Vaccine Immunology, 2009
• Safety and Immunogenicity of a Prepandemic Influenza A (H5N1) Vaccine in Children
  The Pediatric Infectious Disease Journal, 2008
• Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval – a useful approach to pandemic vaccine development even in less well developed countries?
  Influenza and Other Respiratory Viruses, 2008
• Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
  Vaccine, 2008
• A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
  New England Journal of Medicine, 2008
• Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial
  The Lancet, 2007
• Inactivated Whole Virus Influenza A (H5N1) Vaccine1
  Emerging Infectious Diseases, 2007
• An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines
  Journal of Biological Standardization, 1977